Damian Marshall is the Vice President of Analytical Development at Resolution Therapeutics, a UK company developing regenerative macrophage therapies for inflammatory and fibrotic diseases. Prior to joining Resolution Damian spent 2 years as VP of Manufacturing Science and Technology at Achilles Therapeutics and 8 years as Director of New Technologies at the Cell and Gene Therapy Catapult. In these roles he led multi-national programmes working on bioprocess automation, PAT integration and advanced product characterisation.